BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Deep Genomics

Deep Genomics logo

Founded
2014
Geography
Canada based
Funding
$56.700 M

Deep Genomics is using artificial intelligence to build a new universe of life-saving genetic therapies.

The future of medicine will rely on artificial intelligence, because biology is too complex for humans to understand. At Deep Genomics, our geneticists, molecular biologists and chemists develop new ways of detecting and treating disease using our biologically accurate artificial intelligence technology.

Technologies

AI Companies (Drug Discovery)   Gene Therapy Startups  


Posts Mentioning This Company

Biopharma Insights
Biopharma Insights

R&D Platform

Search 69 billion molecules with the goal of generating a library of 1,000 compounds to manipulate cell biology. Allows researchers to: Unlock new classes of antisense oligonucleotide therapies.


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet